Fundamental Analysis
17 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -89.5% | -51.1% | 0 / 3 | -10.3% | -2.94 pp | -0.89 pp | +7.5% | 1.49 | 7.68 | 656 | −10,3% | 0,8 | −89,5% | 7.68 | 4.21 | +82,4% |
| Pts | 0 | 0 | 0 | 0 | 4 | 4 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 8.300 (close price on 2026-10-19)EPS (TTM): 1.081
Financial charts
1.Revenue & growth
VND bn656Q2/26
1.Revenue & growth
VND bn656Q2/26
2.Profit & growth
VND bn0,72Q2/26
3.Profit mix (Penman)
VND bn29,2Q2/26
4.Margins & cost structure
%8.4%Q2/26
5.Returns & cash cycle
% · days5.8%Q2/26
6.Earnings quality & cash
VND bn20,7Q2/26
7.Asset structure
VND bn1.157Q2/26
8.Funding & debt health
VND bn · times1.157Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %7,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %33Q2/26
Adjusted EPS growth, latest quarter
-90.2%
Average adjusted EPS growth, 3 quarters
-51.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26